Ayca Circir

• Amplicon and enrichment based NGS panel development

• Illumina Systems applications such as ISeq and MiniSeq, BioRad CFX and ddPCR, and Opus applications.

• R&D Screening and Diagnostic Kit development, including

RefKit Spinal Muscular Atrophy qPCR Screening Kit - SMN1 (https://refgen.com/en/refkit-spinalmuscular-atrophy-qpcrscreening-kit-smn1/),

RefKit Spinal Muscular Atrophy qPCR Screening Kit SMN1/SMN2 (https://refgen.com/en/refkit-spinalmuscularatrophy-qpcr-screening-kit-smn1-smn2/), and

RefPlex Spinal Muscular Atrophy NGS Kit.

Routine tasks in the kit development process include keeping records of experiments carried out, studying and validating products developed on different devices, taking witness samples for each product and studying them at certain intervals, and reporting all necessary information on the process to the quality control department.

• Conducted independent research projects to investigate roles of candidate genes in cancer metabolism and regulation of candidate genes, developed analytical and problem-solving abilities through data analysis and presentation to lab members, acquired expertise in various biological laboratory techniques, specifically in the field of breast cancer research, gained expertise in presenting in front of the community by making oral presentations at conferences

• Theoretical and practical training at undergraduate level, encouraging environment for academic discussion, testing and evaluating student performances, organization and continuity of laboratories, financial regulation and management in the purchase of laboratory materials and equipment, assisting lecturers in exam processes, gained expertise in laboratory management and improved communication skills

• Fusion Protein-based Recombinant Vaccine Development, bacterial growth and handling/maintenance, gene cloning and PCR applications, recombinant protein production/purification, vaccine formulation

• Fusion Protein-based Recombinant Vaccine Development, gene cloning and PCR applications, recombinant protein production/purification, vaccine formulation